电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

CCL4 蛋白

This Recombinant CCL4 protein is expressed in 大肠杆菌(E. Coli).
产品编号 ABIN7668467
发货至: 中国

Quick Overview for CCL4 蛋白 (ABIN7668467)

抗原

See all CCL4 蛋白
CCL4 (Chemokine (C-C Motif) Ligand 4 (CCL4))

蛋白类型

Recombinant

生物活性

Active

宿主

  • 9
  • 6
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2

资源

  • 25
  • 5
  • 1
  • 1
大肠杆菌(E. Coli)

应用范围

Cell Culture (CC)

纯度

> 98 %
  • 原理

    Recombinant Human CCL4 protein(His Tag)

    序列

    Ala 24-Asn 92

    过滤

    0.2 μm filtered

    内毒素水平

    < 0.1 EU per μg of the protein as determined by the LAL method.

    Biological Activity Comment

    Measure by its ability to chemoattract BaF3 cells transfected with human CCR5.The ED50 for this effect is <10 ng/mL.
  • 想要此Protein的其他选项吗?

    !
    探索我们的预定义定制蛋白和定制蛋白服务!

    您的项目需要进一步定制吗?联系我们,了解我们的定制蛋白解决方案

  • 应用备注

    Optimal working dilution should be determined by the investigator.

    限制

    仅限研究用
  • 状态

    Lyophilized

    缓冲液

    Lyophilized from sterile 50 mM Tris, 150 mM NaCl, pH 8.5.
    Normally 5 % - 8 % trehalose, mannitol and 0.01 % Tween 80 are added as protectants before lyophilization.

    储存条件

    4 °C,-20 °C,-80 °C

    储存方法

    Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80°C. Reconstituted protein solution can be stored at 4-8°C for 2-7 days. Aliquots of reconstituted samples are stable at < -20°C for 3 months.

    有效期

    12 months
  • 抗原

    CCL4 (Chemokine (C-C Motif) Ligand 4 (CCL4))

    别名

    CCL4

    背景

    CCL4 (C-C chemokine ligand 4), is a macrophage inflammatory protein with a chief effect in inflammation and immune-regulation, and was documented in cancer progression by promoting instability in the tumor environment. The inflammatory chemokine (C-C motif) ligand 4 (CCL4) plays an important role in the pathogenesis and progression of cancer. In particular, higher serum CCL4 levels in patients with oral squamous cell carcinoma (OSCC) are associated with a more advanced stage of disease. CCL4 may be a new molecular therapeutic target for inhibition of lymphangiogenesis and metastasis in OSCC. CCL3 and CCL4 loci may be marker SNPs for risk of HCV treatment outcome. CCL4 can enhance the recruitment of preosteoclasts to bone in the early stage, and the reduction of CCR5 promotes osteoclastogenesis when RANKL is prevalent.,ACT-2,MIP-1b: Macrophage Inflammatory Protein-1β

    分子量

    calculated_mw: 7.8 kDa

    observed_mw: 11 kDa

    UniProt

    P13236
You are here:
Chat with us!